Industry

Tevogen Bio CEO and CSO share concerns of the White House and President Joe Biden who stated, “New variants may make some existing protections ineffective for the immunocompromised” and promise to do everything in their power to accelerate development and manufacturing of its investigational therapy, TVGN-489 A comprehensive review by the company’s R&D team found … [Read more…]

– Annual Survey has Ranked Alnylam within the Top Three on the Best Employers List Since 2019 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its second place ranking in Science Magazine’s 2022 Top Employer Survey. This marks the fourth year Alnylam was featured as one of the top … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe CAR-T Cell Therapy Market Size, Trends & Growth Opportunity, By Type, By Application, By End-user By country and Forecast till 2027.” report has been added to ResearchAndMarkets.com’s offering. The Europe CAR-T Cell Therapy market was valued at USD 396.21 Mn in 2021 which expected to reach USD 1,904.40 Mn by 2027 at … [Read more…]

Consultation and resources available at no cost to local community FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the high school shooting that occurred in St. Louis, Missouri on Monday. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential … [Read more…]

New guidelines from Kidney Disease: Improving Global Outcomes (KDIGO) and a consensus report jointly issued from KDIGO and the American Diabetes Association (ADA) include KERENDIA as part of a comprehensive treatment strategy for patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) who have an estimated glomerular filtration rate of >25 mL/min/1.73 … [Read more…]

Healthcare providers Dr. Matthew Womack and Dr. James Waldschmidt held accountable for negligence ATLANTA–(BUSINESS WIRE)–A Fulton County jury ruled in favor of a Georgia man after a stroke and subsequent medical negligence left him with “locked-in syndrome,” cognitively aware but unable to move any part of his body other than his eyes. Plaintiff Jonathan Buckelew … [Read more…]

The international technical design and development event for robotics and intelligent systems seeks compelling speakers for each of the tracks CLEVELAND–(BUSINESS WIRE)–WTWH Media invites you to submit a session abstract to be considered for presentation at the Robotics Summit & Expo or the Healthcare Robotics Engineering Forum (HREF), being held May 10-11, 2023 at the … [Read more…]

A new peer-reviewed journal paper suggests that crushing GEMTESA (vibegron) 75-mg and taking it with applesauce may be an appropriate option for people with overactive bladder (OAB) and concommitant swallowing difficulties. Results from this Phase 1 study show that vibegron can be crushed and mixed with applesauce with no clinically meaningful change to pharmacokinetic (PK) … [Read more…]

Former executive director of human resources and interim chief human resources officer succeeds newly retired leader, Linda Lang GREENBRAE, Calif.–(BUSINESS WIRE)–MarinHealth today announced the selection and promotion of its interim chief human resources officer, Eugene Lewis, who will fill the role of chief human resources officer. Lewis succeeds Linda Lang JD, a former senior leader … [Read more…]

VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today announced that data from multiple studies of LUPKYNIS® (voclosporin) will be presented at the American Society of Nephrology (ASN) Kidney Week 2022, taking place November 3-6 in Orlando, Florida. … [Read more…]